This is one of two volumes covering the latest developments in the field of purinergic and pyrimidinergic transmission, going into the roles of those signaling systems in tissue function and pathophysiology and advances in developing potential new medications based on the modulation of P1 and P2 receptor signaling processes. HEP 151 II centers on the cardiovascular, renal, immune and endocrine systems.